To include your compound in the COVID-19 Resource Center, submit it here.

MG98: Began Phase II trial

(Interim Phase I data, B12)

MethylGene Inc., Montreal, Quebec
Product: MG98
Business:

Read the full 126 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE